The posting
About the Company We’re an early-stage, venture-backed AI company (Series A, backed by investors with deep roots in technology and life sciences) building software for pharma and biotech regulatory teams. Our platform helps regulatory affairs and medical writing groups produce the documents drug approvals depend on, work that has traditionally taken large teams weeks of manual effort. Our founders previously built and led a clinical research technology company, and we’re already live with...



